Modafinil as antidepressant augmentation therapy in major depressive disorder

被引:0
|
作者
Thase, ME
DeBattista, C
Fava, M
机构
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[3] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA 02114 USA
关键词
D O I
10.1016/S0924-977X(04)80175-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S210 / S211
页数:2
相关论文
共 50 条
  • [31] Augmentation of Dopaminergic Agents for Major Depressive Disorder
    Pae, Chi-Un
    Patkar, Ashwin A.
    Masand, Prakash S.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 432 - 433
  • [32] Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder
    Dunlop, Boadie W.
    Cole, Steven P.
    Nemeroff, Charles B.
    Mayberg, Helen S.
    Craighead, W. Edward
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 229 : 111 - 119
  • [33] Modafinil as augmentation of SSRI monotherapy in major depressive disorder: A 12-week, open-label extension study
    Thase, ME
    Fava, M
    DeBattista, C
    Fannelli, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S238 - S238
  • [34] Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12-week, open-label, extension study
    Thase, ME
    Fava, M
    DeBattista, C
    Arora, S
    Hughes, RJ
    [J]. CNS SPECTRUMS, 2006, 11 (02) : 93 - 102
  • [35] Multimodal antidepressant in Major Depressive Disorder: Use of vortioxetine in depressive outpatients
    Santamaria, O.
    Romero, S. L.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S279 - S280
  • [36] ANTIDEPRESSANT RESPONSE IN MAJOR DEPRESSIVE DISORDER AND RARE VARIANTS
    Wong, Ma-Li
    Arcos-Burgos, Mauricio
    Licinio, Julio
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1304 - 1304
  • [37] Efficacy of Antidepressant Medication in the Treatment of Major Depressive Disorder
    Anderson, Benjamin
    Muller, Andrew
    [J]. ARCHIVES OF CLINICAL PSYCHIATRY, 2023, 50 (01) : 123 - 129
  • [38] Personalized antidepressant treatment for patients with major depressive disorder
    Chin, Tracy
    Huyghebaert, Trudy
    Svrcek, Clark
    Oluboka, Oloruntoba
    [J]. CANADIAN FAMILY PHYSICIAN, 2022, 68 (11) : E301 - E309
  • [39] Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
    Gonda, Xenia
    Sharma, Samata R.
    Tarazi, Frank I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (01) : 81 - 89
  • [40] Antidepressant adherence among outpatients with major depressive disorder
    Yassen, Ali Omar
    Mahmud, Nasraw Mustafa
    Bilal, Aya Diyar
    Wahab, Mohd Shahezwan Abd
    [J]. PHARMACIA, 2024, 71